These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1336750)

  • 1. [3H]PN200-110 and [3H]glibenclamide binding in normal and cardiomyopathic hamsters.
    Miller JA; Chmielewski PA; Rampe D
    Gen Pharmacol; 1992 Nov; 23(6):1153-7. PubMed ID: 1336750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (+)-[3H]isradipine and [3H]glyburide bindings to heart and lung membranes from rats with monocrotaline-induced pulmonary hypertension.
    Nakayama K; Fukuta Y; Kiyoshi A; Iwatsuki Y; Ishii K; Ishikawa T; Iida M; Iwata H; Enomoto M
    Jpn J Pharmacol; 1999 Oct; 81(2):176-84. PubMed ID: 10591475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of ATP-sensitive K+ channels by chronic glyburide and pinacidil administration.
    Gopalakrishnan M; Triggle DJ
    Biochem Pharmacol; 1992 Nov; 44(9):1843-7. PubMed ID: 1333209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydropyridine receptor binding sites in the cardiomyopathic hamster heart are unchanged from control.
    Bazan E; Sole MJ; Schwartz A; Johnson CL
    J Mol Cell Cardiol; 1991 Feb; 23(2):111-7. PubMed ID: 1648625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ryanodine and dihydropyridine binding patterns and ryanodine receptor mRNA levels in myopathic hamster heart.
    Lachnit WG; Phillips M; Gayman KJ; Pessah IN
    Am J Physiol; 1994 Sep; 267(3 Pt 2):H1205-13. PubMed ID: 8092287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoaffinity labeling of the calcium channel antagonist receptor in the heart of the cardiomyopathic hamster.
    Kuo TH; Johnson DF; Tsang W; Wiener J
    Biochem Biophys Res Commun; 1987 Nov; 148(3):926-33. PubMed ID: 2446613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
    Murphy BJ; Tuana BS
    Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ATP on specific [3H](+)-isradipine binding in rat ventricular cardiomyocytes.
    Stokke M; Hagelin EM; Brørs O
    Eur J Pharmacol; 1996 May; 303(1-2):115-22. PubMed ID: 8804919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]-nitrendipine binding sites in normal and cardiomyopathic hamsters: absence of a selective increase in putative calcium channels in cardiomyopathic hearts.
    Howlett SE; Rafuse VF; Gordon T
    Cardiovasc Res; 1988 Nov; 22(11):840-6. PubMed ID: 2855722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of [3H]isradipine binding to L-type calcium channels by the optical isomers of isoflurane. Lack of stereospecificity.
    Moody EJ; Harris B; Hoehner P; Skolnick P
    Anesthesiology; 1994 Jul; 81(1):124-8. PubMed ID: 8042780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inotropic and calcium kinetic effects of calcium channel agonist and antagonist in isolated cardiac myocytes from cardiomyopathic hamsters.
    Sen LY; O'Neill M; Marsh JD; Smith TW
    Circ Res; 1990 Sep; 67(3):599-608. PubMed ID: 1697792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-channel opening activity of dihydropyridine ZM244085: effect on 86Rb efflux and 3H-P1075 binding in urinary bladder smooth muscle.
    Trivedi S; Potter-Lee L; McConville MW; Li JH; Ohnmacht CJ; Trainor DA; Kau ST
    Res Commun Mol Pathol Pharmacol; 1995 May; 88(2):137-51. PubMed ID: 7670846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity hippocampal [3H]-glibenclamide binding sites are preserved in Alzheimer's disease.
    Ikeda M; Dewar D; McCulloch J
    J Neural Transm Park Dis Dement Sect; 1993; 5(3):177-84. PubMed ID: 8369099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oxygen free radicals on calcium current and dihydropyridine binding sites in guinea-pig ventricular myocytes.
    Guerra L; Cerbai E; Gessi S; Borea PA; Mugelli A
    Br J Pharmacol; 1996 Jul; 118(5):1278-84. PubMed ID: 8818354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-sensitive K-channels in HIT T15 beta-cells studied by patch-clamp methods, 86Rb efflux and glibenclamide binding.
    Niki I; Kelly RP; Ashcroft SJ; Ashcroft FM
    Pflugers Arch; 1989 Oct; 415(1):47-55. PubMed ID: 2516306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in cardiac SR Ca(2+)-release channels during development of heart failure in cardiomyopathic hamsters.
    Ueyama T; Ohkusa T; Hisamatsu Y; Nakamura Y; Yamamoto T; Yano M; Matsuzaki M
    Am J Physiol; 1998 Jan; 274(1):H1-7. PubMed ID: 9458845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of high affinity [3H]glibenclamide binding sites within the substantia nigra zona reticulata of the rat brain.
    Hicks GA; Hudson AL; Henderson G
    Neuroscience; 1994 Jul; 61(2):285-92. PubMed ID: 7969909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropharmacological characterization of voltage-sensitive calcium channels: possible existence of neomycin-sensitive, omega-conotoxin GVIA- and dihydropyridines-resistant calcium channels in the rat brain.
    Yamada K; Teraoka T; Morita S; Hasegawa T; Nabeshima T
    Jpn J Pharmacol; 1993 Dec; 63(4):423-32. PubMed ID: 8121077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-sensitive potassium channels are not expressed in brain microvessels.
    Sullivan HC; Harik SI
    Brain Res; 1993 May; 612(1-2):336-8. PubMed ID: 8330209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotides modulate the low affinity binding sites for [3H]glibenclamide in the rat brain.
    Zini S; Zini R; Ben-Ari Y
    J Pharmacol Exp Ther; 1993 Feb; 264(2):701-8. PubMed ID: 8437118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.